Cargando…

Senescence marker protein 30 inhibits tumor growth by reducing HDAC4 expression in non-small cell lung cancer

BACKGROUND: Senescence marker protein 30 (SMP30), which plays a pivotal role as a suppressor protein in cell proliferation, among other regulatory actions, is a marker of aging that shows decreased expression during senescence. Decreased SMP30 has been identified in several human cancers, but its ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Changjian, Guo, Kai, Xu, Liqun, Zhang, Yimeng, Duan, Hongtao, Feng, Yingtong, Pan, Minghong, Lu, Di, Ren, Xiaoya, Ganti, Apar Kishor, Hakozaki, Taiki, Han, Jing, Yan, Xiaolong, Ma, Zhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743512/ https://www.ncbi.nlm.nih.gov/pubmed/35070761 http://dx.doi.org/10.21037/tlcr-21-982

Ejemplares similares

WNT5A promotes the metastasis of esophageal squamous cell carcinoma by activating the HDAC7/SNAIL signaling pathway
por: Feng, Yingtong, et al.
Publicado: (2022)

HDAC7/c-Myc signaling pathway promotes the proliferation and metastasis of choroidal melanoma cells
por: Zhang, Yimeng, et al.
Publicado: (2023)

Identification of the pyroptosis-related gene signature and risk score model for esophageal squamous cell carcinoma
por: Pan, Minghong, et al.
Publicado: (2023)

Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
por: Ding, Peng, et al.
Publicado: (2022)

The value of WNT5A as prognostic and immunological biomarker in pan-cancer
por: Feng, Yingtong, et al.
Publicado: (2022)

Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
por: Ding, Peng, et al.
Publicado: (2022)

Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment
por: Wang, Yuanyong, et al.
Publicado: (2022)

Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
por: Yellala, Amulya, et al.
Publicado: (2020)

Cisplatin or carboplatin for advanced non-small cell lung cancer: does it really matter?
por: Kesireddy, Meghana, et al.
Publicado: (2021)

Promising trends in lung cancer care, but are we overlooking the majority?
por: Sharma, Bhavina, et al.
Publicado: (2023)

Clinical Utility of Mobocertinib in the Treatment of NSCLC – Patient Selection and Reported Outcomes
por: Arnold, Abram, et al.
Publicado: (2023)

HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway
por: Guo, Kai, et al.
Publicado: (2022)

EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
por: Reade, Chad A, et al.
Publicado: (2009)

Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)
por: Duan, Hongtao, et al.
Publicado: (2022)

The mitosis-related gene OIP5 is a potential biomarker in pan-cancer
por: Pan, Minghong, et al.
Publicado: (2023)

Current concepts in the management of small cell lung cancer
por: Ganti, Apar Kishor, et al.
Publicado: (2013)

Mitosis-related gene CENP-U as a potential biomarker in malignancy
por: Shao, Changjian, et al.
Publicado: (2021)

Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I–III non-small cell lung cancer (NSCLC) patients with baseline tissue EGFR mutations
por: Guo, Kai, et al.
Publicado: (2021)

Pancytopenia due to iron deficiency worsened by iron infusion: a case report
por: Ganti, Apar Kishor, et al.
Publicado: (2007)

Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma
por: Macha, Muzafar A, et al.
Publicado: (2013)

Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database
por: Anggondowati, Trisari, et al.
Publicado: (2020)

HDACs and the senescent phenotype of WI-38 cells
por: Place, Robert F, et al.
Publicado: (2005)

HDAC4 Inhibitors as Antivascular Senescence Therapeutics
por: Huang, Chuoji, et al.
Publicado: (2022)

Exertional Chest Pain and Dyspnea From Hyperviscosity Syndrome Related to Marginal Zone Lymphoma
por: Dhakal, Prajwal, et al.
Publicado: (2014)

Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non–small-cell lung cancer in the USA
por: Li, Yulin, et al.
Publicado: (2019)

Correction: Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA
por: Li, Yulin, et al.
Publicado: (2019)

Characterizing Immune Checkpoint Inhibitor-Induced Hypophysitis and Obstacles in Diagnosis
por: Johnson, Jake, et al.
Publicado: (2021)

Weight Loss and Percutaneous Endoscopic Gastrostomy Tube Placement during Chemoradiotherapy for Locally Advanced Cancer of the Oropharynx Do Not Negatively Impact Outcomes
por: Baine, Michael J., et al.
Publicado: (2017)

Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma
por: Mo, Zhijing, et al.
Publicado: (2016)

Expressions of Senescence-Associated β-Galactosidase and Senescence Marker Protein-30 are Associated with Lens Epithelial Cell Apoptosis
por: Zhou, Dan, et al.
Publicado: (2015)

The DNA damage repair-related gene PKMYT1 is a potential biomarker in various malignancies
por: Shao, Changjian, et al.
Publicado: (2021)

Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay
por: Lv, Sa, et al.
Publicado: (2008)

Senescence Marker Protein 30 (SMP30) Expression in Eukaryotic Cells: Existence of Multiple Species and Membrane Localization
por: Arun, Peethambaran, et al.
Publicado: (2011)

HER-2/neu and CD117 (c-kit) overexpression in patients with pesticide exposure and extensive stage small cell lung carcinoma (ESSCLC)
por: Potti, Anil, et al.
Publicado: (2005)

Risk of malignancy in patients with chronic kidney disease
por: Tendulkar, Ketki K., et al.
Publicado: (2022)

Senescence Marker Protein 30 (SMP30): A Novel Pan-Species Diagnostic Marker for the Histopathological Diagnosis of Breast Cancer in Humans and Animals
por: Baek, Su-Min, et al.
Publicado: (2021)

PD-L1 expression in small cell lung cancer: should we designate it for assignment?
por: Hakozaki, Taiki
Publicado: (2021)

Re-administration of immune checkpoint inhibitors for patients with non-small cell lung cancer
por: Hakozaki, Taiki
Publicado: (2022)

Quantitative spatial profiling of PD-1/PD-L1 interaction in patients with cancer
por: Hakozaki, Taiki
Publicado: (2023)

Deficiency of Senescence Marker Protein 30 Exacerbates Cardiac Injury after Ischemia/Reperfusion
por: Kadowaki, Shinpei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bimvh7rggk1hii0nlhqm3fng10